People · Operator
Named in public records as an officer, director or promoter · active 2009–2016 · Biotechnology, Pharmaceuticals
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Tobira Therapeutics, Inc. | — | Biotechnology | Series A | $23.2M | $513.3M | 2010 |
| Adynxx, Inc. | — | Pharmaceuticals | Series B | $21.5M | $544.1M | 2010 |
| Sequel Pharmaceuticals Inc | — | Pharmaceuticals | Seed | $5.4M | $38.0M | 2009 |
Eckard Weber at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Eckard Weber on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Patrick Heron | 1 | 11 |
| Nina Kjellson | 1 | 11 |
| Heath Lukatch | 1 | 10 |
| Brian Halak | 1 | 10 |
| James Sapirstein | 1 | 7 |
| Dennis Podlesak | 1 | 6 |
| Rick Orr | 1 | 5 |
| David Lowe | 1 | 5 |
| Laurent Fischer | 1 | 4 |
| Scott Harris | 1 | 4 |
| Joseph Turner | 1 | 4 |
| Stuart J.M. Collinson | 1 | 4 |
| Daniel Turner | 1 | 4 |
| Stan Abel | 1 | 3 |
| Carol Brosgart | 1 | 3 |
| Howard C. Dittrich | 1 | 2 |
| Daniel K. Turner, III | 1 | 2 |
| Randall Woods | 1 | 2 |
| Paul K. Chamberlain | 1 | 1 |
| Brian K. Farmer | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.